The Iliac/SFA/Popliteal Center

Filter Your Results




Intact Vascular Launches the Tack Endovascular System in the United States

May 6, 2019 -- Intact Vascular, Inc. announced the first commercial use of its Tack endovascular system in multiple sites across the United States. This dissection repair devi…

Two-Year MIMICS-2 Data Support Veryan's BioMimics 3D Stent System in Femoropopliteal Arteries

May 1, 2019 -- At the 2019 Charing Cross Symposium, held April 15 -- 18 in London, United Kingdom, Timothy Sullivan, MD, presented data from the MIMICS-2 trial that showed tha…

FDA Schedules Public Meeting on Paclitaxel Use in PAD

April 22, 2019 -- The FDA announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee will convene a public meeting to discuss and make recom…

Cook Medical Provides Patient-Level Paclitaxel Data From Zilver PTX Randomized Controlled Trial

April 18, 2019 -- Cook Medical announced that patient-level data from the Zilver PTX randomized controlled trial (RCT) of the company's paclitaxel-eluting peripheral stent…

Two-Year Data Presented From BIOLUX P-III Registry of Biotronik's Passeo-18 Lux DCB

April 18, 2019 -- Biotronik announced that 2-year data from the BIOLUX P-III all-comers registry of the company's Passeo-18 Lux drug-coated balloon (DCB) were presented at…

Case Report: Successful Revascularization Utilizing Excimer Laser Photoablation After Failed Attempts With Other Modalities in a CLI Patient Presenting With Acute Limb Ischemia

Mohammad M. Ansari, MD; and Marina S. Iskandir, MD

April 2019—Patients with critical limb ischemia (CLI) have a 1-year mortality rate of 20% and a 1-year limb loss rate of 20%.1 Amputees have an increased mortality rate of 48% at 1 year …

Treatment Strategies for Femoropopliteal Chronic Total Occlusions

Harry W. Donias, MD

April 2019—A chronic total occlusion (CTO) is present in nearly 50% of all patients undergoing endovascular treatment of infrainguinal peripheral arteries.1 The presence of a CTO has bee…

Enrollment Resumes in the TRANSCEND Trial of Surmodics' SurVeil Paclitaxel-Coated Balloon

April 17, 2019 -- Surmodics, Inc. announced that it has resumed patient enrollment for the TRANSCEND clinical trial and has completed approximately 75% of its goal of enrollin…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.